Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative octreotide before surgery for TSH-secreting pituitary adenoma
ChiCTR2000030523Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Mar 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of octreotide in TSH-secreting adenoma (TSHoma) (2 arms), sponsored by Xinqiao Hospital. Primary endpoints: Thyroid hormones, Sellar MRI scan with contrast enhancement and 4 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
octreotide
03
Conditions
TSH-secreting adenoma (TSHoma)
Beyond the preview
Go deeper on ChiCTR2000030523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030523.